Rice Hall James & Associates, LLC has filed its 13F form on October 16, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.72 Billion distributed in 248 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arlo Technologies, Inc. with a value of $58.9M, Aci Worldwide, Inc. with a value of $52.6M, Ligand Pharmaceuticals Inc with a value of $52.2M, Medpace Holdings, Inc. with a value of $47M, and Stride, Inc. with a value of $45.5M.

Examining the 13F form we can see an increase of $29.1M in the current position value, from $1.69B to 1.72B.

Below you can find more details about Rice Hall James & Associates, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.72 Billion
Healthcare: $560 Million
Technology: $456 Million
Industrials: $326 Million
Consumer Cyclical: $122 Million
Financial Services: $83.8 Million
Consumer Defensive: $73.4 Million
Communication Services: $64.5 Million
Basic Materials: $27.9 Million
Other: $5.46 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 248
  • Current Value $1.72 Billion
  • Prior Value $1.69 Billion
  • Filing
  • Period Q3 2025
  • Filing Date October 16, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 14 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 198 stocks
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.